Exhaled Nitric Oxide and Pulmonary Oxygen Toxicity Susceptibility

Exhaled Nitric Oxide

Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis.

Cytokines such as tumour necrosis factor-alpha and interferon gamma are associated with active pulmonary inflammation in sarcoidosis and they upregulate inducible nitric oxide synthase (iNOS). The objectives of this study were to examine iNOS upregulation in sarcoidosis by showing raised exhaled nitric oxide and increased iNOS activity in lung biopsy specimens of these patients utilizing immuno...

Exhaled nitric oxide and COPD.

We were interested to read the paper by LEHTIMÄKI et al. [1] recently published in the European Respiratory Journal, in which those authors reported that ‘‘high pre-treatment levels of J9aw,NO [bronchial nitric oxide flux] are related to symptom relief and improvement of airway obstruction’’ when inhaled fluticasone is given to patients with chronic obstructive pulmonary disease (COPD). Their d...

Exhaled nitric oxide in chronic obstructive pulmonary disease.

Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow obstruction and a neutrophilic inflammation. Exhaled nitric oxide (NO) may be a marker of disease activity in a variety of lung diseases. We measured exhaled NO in patients with documented COPD and investigated whether the concentration of exhaled NO is related to the severity of disease as defined by lung func...

Exhaled nitric oxide is not increased in pulmonary sarcoidosis.

BACKGROUND Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker of airway inflammation and nitrosative stress. Previous studies have suggested a possible role of FeNO in the management of patients with pulmonary sarcoidosis, but published data are discordant. OBJECTIVES To assess the clinical usefulness of FeNO and alveolar concentration of NO (CalvNO) in sarcoidosis. METHODS ...